Skip to content
PlaceLab Network

Administering Pluripotent Cells in Utero to Babies with Spina Bifida Boosts Life Outcomes, Trial Finds

A groundbreaking clinical study has found that delivering regenerative cells to developing infants suffering from spina bifida while undergoing fetal surgery may represent a "important advancement" in treating birth defects.

Trial Details and Safety

The US-based trial examined six fetuses with myelomeningocele. Medical teams placed regenerative cells sourced from the maternal placenta on the exposed area of the developing neural column as part of the surgical correction.

Importantly, the cell therapy proved to be secure. The study team reported that the therapy did not induce cancerous growths, hinder surgical recovery, or prevent the reversal of related neurological issues.

Encouraging Results

Imaging conducted after delivery showed a successful correction of hindbrain herniation in each of the babies. This favorable anatomical change is a key indicator for better mobility and function.

"Should it enable additional babies to achieve ambulation who otherwise would not, it could establish itself as the conventional approach," said the lead researcher. "The outcomes appear profoundly encouraging and open the door to numerous possible innovative interventions."

Long-Term Prospects and Optimism

Experts not involved in the trial indicated that additional validation of these observed advantages could herald a "different age" in in-utero treatment. The possibility of ameliorating neurological damage seen in utero is viewed as a revolutionary objective.

Notably important would be improvements in continence and digestive health, which are common challenges for individuals living with this condition.

Looking Ahead

While this initial trial was small in scale, its established security and encouraging indicators provide a strong foundation for larger, more comprehensive studies. The combination of regenerative medicine with established fetal surgery techniques presents significant potential for transforming outcomes for babies yet to be born with this neural tube defect.

By

Christine Avery

Elena is an urban researcher and writer passionate about smart cities and community-driven development.

PlaceLab Network

Type to search articles.